Morgan Stanley Downgrades Immuneering Corporation (IMRX) to Underweight

Morgan Stanley analyst Jeffrey Hung downgraded Immuneering Corporation (NASDAQ: IMRX) from Equalweight to Underweight.The analyst comments:...
5 days ago
from: StreetInsider

Morgan Stanley, Nasdaq

More about this

- Immuneering (NASDAQ:IMRX) Lowered to Underweight Rating by Morgan Stanley
Morgan Stanley downgraded shares of Immuneering from an "equal weight" rating to an "underweight" rating in a research report on Friday.
from: MarketBeat

- Immuneering Co. (NASDAQ:IMRX) Given Average Rating of "Hold" by Analysts
Shares of Immuneering Co. (NASDAQ:IMRX - Get Free Report) have been given a consensus rating of "Hold" by the eight brokerages that are...
from: MarketBeat